State Street Corp Tenaya Therapeutics, Inc. Transaction History

State Street Corp

  • $2.21 Trillion
  • Q1 2024

A detailed history of State Street Corp transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 969,297 shares of TNYA stock, worth $4.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
969,297
Previous 919,222 5.45%
Holding current value
$4.08 Million
Previous $2.98 Million 70.21%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$2.88 - $6.8 $144,216 - $340,510
50,075 Added 5.45%
969,297 $5.07 Million
Q4 2023

Feb 14, 2024
BUY
$1.73 - $3.39 $69,475 - $136,139
40,159 Added 4.57%
919,222 $2.98 Million
Q3 2023

Nov 14, 2023
BUY
$2.55 - $5.65 $145,005 - $321,287
56,865 Added 6.92%
879,063 $2.24 Million
Q2 2023

Aug 14, 2023
BUY
$2.64 - $7.64 $859,050 - $2.49 Million
325,398 Added 65.5%
822,198 $4.83 Million
Q1 2023

May 15, 2023
BUY
$1.92 - $3.59 $133,839 - $250,251
69,708 Added 16.32%
496,800 $1.42 Million
Q4 2022

Feb 14, 2023
BUY
$1.68 - $3.19 $37,509 - $71,223
22,327 Added 5.52%
427,092 $858,000
Q3 2022

Nov 15, 2022
BUY
$2.9 - $5.88 $41,594 - $84,336
14,343 Added 3.67%
404,765 $1.17 Million
Q2 2022

Aug 15, 2022
BUY
$5.01 - $14.12 $476,115 - $1.34 Million
95,033 Added 32.17%
390,422 $2.2 Million
Q1 2022

May 16, 2022
BUY
$9.41 - $19.3 $755,792 - $1.55 Million
80,318 Added 37.34%
295,389 $3.48 Million
Q4 2021

Feb 14, 2022
BUY
$18.41 - $29.58 $602,632 - $968,271
32,734 Added 17.95%
215,071 $4.08 Million
Q3 2021

Nov 15, 2021
BUY
$15.35 - $26.66 $2.8 Million - $4.86 Million
182,337 New
182,337 $3.77 Million

Others Institutions Holding TNYA

# of Institutions
90
Shares Held
47.2M
Call Options Held
35.8K
Put Options Held
1.1K
View Full List

About Tenaya Therapeutics, Inc.

TNYA Quotes by TradingView
  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $174M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email